ArticlePloS one2014

Phosphodiesterase 3/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition.

Liping Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.